VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 121 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,653 | +97.7% | 31,181 | +192.1% | 0.00% | – |
| Q2 2023 | $122,229 | -63.3% | 10,675 | -75.3% | 0.00% | -100.0% |
| Q1 2023 | $333,080 | +117.7% | 43,201 | +115.3% | 0.00% | 0.0% |
| Q1 2022 | $153,000 | +282.5% | 20,066 | +35.4% | 0.00% | – |
| Q4 2021 | $40,000 | -54.0% | 14,818 | -55.4% | 0.00% | – |
| Q3 2021 | $87,000 | -76.0% | 33,257 | -62.2% | 0.00% | -100.0% |
| Q2 2021 | $363,000 | +441.8% | 87,960 | +518.2% | 0.00% | – |
| Q1 2021 | $67,000 | -96.2% | 14,229 | -88.8% | 0.00% | -100.0% |
| Q4 2019 | $1,774,000 | -29.8% | 127,179 | -13.3% | 0.01% | -52.2% |
| Q3 2019 | $2,526,000 | +667.8% | 146,770 | +319.5% | 0.02% | +475.0% |
| Q4 2018 | $329,000 | +15.0% | 34,983 | +131.7% | 0.00% | +33.3% |
| Q3 2018 | $286,000 | -22.1% | 15,100 | -19.7% | 0.00% | -40.0% |
| Q2 2018 | $367,000 | +60.3% | 18,800 | +36.5% | 0.01% | +25.0% |
| Q4 2017 | $229,000 | – | 13,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |